Short answer
Designers can leverage advanced 3D modelling and bioprinting techniques to create patient-specific medical devices with controlled release functionalities for targeted therapeutic applications.
- Field
- Modelling
- Source
- Scientific Reports (2020)
- Method
- Experimental and Simulation
- Sample
- 1 rat (in-vivo testing)
- Evidence
- Strong effect
Ultra-fast bioprinting of 5D digital models allows for the creation of drug-eluting vascular coatings that rapidly release nanoparticles in vivo. This modelling research insight is drawn from a 2020 study published in Scientific Reports. Using Experimental and simulation with 1 rat (in-vivo testing), researchers explored how this design variable affects real-world outcomes. The key design takeaway: Designers can leverage advanced 3D modelling and bioprinting techniques to create patient-specific medical devices with controlled release functionalities for targeted therapeutic applications.
5D Bioprinting of Drug-Eluting Vascular Devices Achieves Rapid In-Vivo Nanoparticle Release
Ultra-fast bioprinting of 5D digital models allows for the creation of drug-eluting vascular coatings that rapidly release nanoparticles in vivo.
Scientific Reports · 2020
Key Findings
- 01A 5D digital model of a human peripheral artery was successfully translated into an additively manufactured, drug-eluting vascular coating.
- 02The nanoparticle-loaded coating demonstrated rapid dissolution in vivo, releasing nanoparticles that were quickly absorbed by vascular cells.
- 03The RFP bioprinting method allowed for the creation of high-resolution, self-dissolving devices.
Application
Design takeaway
Designers can leverage advanced 3D modelling and bioprinting techniques to create patient-specific medical devices with controlled release functionalities for targeted therapeutic applications.
How to apply
Utilise CT or MRI scan data to create detailed 3D models of anatomical structures, then use these models to guide the design and fabrication of custom medical implants or drug delivery systems via additive manufacturing.
Project actions
- 01When modelling complex biological structures, consider how the digital model will be translated into a physical object.
- 02Explore how different materials and fabrication methods can influence the performance of a medical device, such as drug release rates.
Method & Evidence
Variables
Strengths & Limitations
Strengths
- +Innovative integration of digital modelling and bioprinting.
- +Demonstration of in-vivo feasibility for a novel medical application.
Limitations
The study used a single animal, so results might not apply to all individuals. The long-term effects of the nanoparticles were not studied.
Reliability & validity
The study's validity is supported by the use of a reconstructed anatomical model and in-vivo testing. However, the reliability of the findings might be limited by the small sample size (n=1 for in-vivo testing), suggesting a need for further replication with larger cohorts.
Think critically
How might the '5D' aspect of the digital model (beyond just length, width, and height) influence the design and functionality of the vascular device, and what are the limitations of this approach?
Design Principles
"Integrate patient-specific anatomical data with advanced fabrication techniques to create personalised therapeutic devices."
This research demonstrates a novel approach to personalised medicine by integrating advanced 3D modelling with bioprinting technology. The ability to precisely create patient-specific medical devices with controlled drug release mechanisms opens new avenues for targeted therapies and improved patient outcomes.
What This Means for Your Design
Imagine creating a custom-fit bandage that releases medicine exactly where it's needed in your body, based on a 3D scan of your injury. This research shows how that's becoming possible for blood vessels.
How to use in your project
- 1.Reference this study when discussing the use of 3D modelling and bioprinting for creating personalised medical devices or drug delivery systems.
Add to My Project
Quick Cite
Paragraph starter
The development of 5D digital models and their translation into ultra-fast bioprinted vascular devices, as demonstrated by Foresti et al. (2020), offers a significant advancement in personalised nanomedicine by enabling the creation of custom drug-eluting coatings with rapid in-vivo nanoparticle release capabilities.
Source
Scientific Reports
In-vivo vascular application via ultra-fast bioprinting for future 5D personalised nanomedicine
journal · 2020
View sourceQuestions About This Research
- What does the research say about 5d bioprinting of drug-eluting vascular devices achieves rapid in-vivo nanoparticle release?
- Designers can leverage advanced 3D modelling and bioprinting techniques to create patient-specific medical devices with controlled release functionalities for targeted therapeutic applications. Evidence: Scientific Reports (2020).
- Why does "5D Bioprinting of Drug-Eluting Vascular Devices Achieves Rapid In-Vivo Nanoparticle Release" matter for design?
- This research demonstrates a novel approach to personalised medicine by integrating advanced 3D modelling with bioprinting technology. The ability to precisely create patient-specific medical devices with controlled drug release mechanisms opens new avenues for targeted therapies and improved patient outcomes.
- How can designers apply this research?
- Designers can leverage advanced 3D modelling and bioprinting techniques to create patient-specific medical devices with controlled release functionalities for targeted therapeutic applications.
- What were the main findings?
- A 5D digital model of a human peripheral artery was successfully translated into an additively manufactured, drug-eluting vascular coating.. The nanoparticle-loaded coating demonstrated rapid dissolution in vivo, releasing nanoparticles that were quickly absorbed by vascular cells.. The RFP bioprinting method allowed for the creation of high-resolution, self-dissolving devices.
- What research method was used?
- Experimental and Simulation with 1 rat (in-vivo testing).
- How strong is the evidence?
- Evidence strength is rated Strong effect, based on a 2020 journal from Scientific Reports.
- What should I do differently in my next project?
- Utilise CT or MRI scan data to create detailed 3D models of anatomical structures, then use these models to guide the design and fabrication of custom medical implants or drug delivery systems via additive manufacturing.
- What are the limitations?
- The in-vivo study was conducted on a single animal model, and further extensive testing is required to confirm efficacy and safety across diverse biological systems and patient populations. The long-term effects of nanoparticle absorption were not fully investigated.